- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03652220
Meditation Based Lifestyle Modification in Depression (MBLM-D)
Meditation Based Lifestyle Modification in Depression: a Randomized Controlled Trial
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sachsen
-
Colditz, Sachsen, Germany, 04680
- Diakoniekliniken Zschadraß
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Subjects must meet the following criteria to be enrolled:
- Outpatients
- Written informed consent by patients who are competent to consent to study participation
- Diagnosis of current mild or moderate episode of depression diagnosed by a consultant psychiatrist
- Male or female ≥18 years of age
- BDI-II >= 10
- Patients must be physically able to perform simple Yoga postures and to sit silently for 20 minutes
Exclusion Criteria:
Patients will be excluded for ANY ONE of the following reasons:
- Psychotic Symptoms
- Acute suicidal tendencies
- Compulsive disorders
- Cerebro-organic diseases with clinically relevant symptoms
- Severe multimorbidity
- Clinically relevant addictions (tobacco abuse or addiction is allowed)
- Current participation in another trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
8 weeks Minimal treatment + MBLM 16 weeks Multimodal specific treatment + MBLM Consolidation Definitions Minimal treatment: drug continuation under medical supervision Multimodal specific treatment: Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR MBLM: 8-week course Meditation Based Lifestyle Modification MBLM-Consolidation: weekly Mantra-Meditation, monthly Life-Ethics |
8 weekly modules, each 3.5 hours of Life ethics, Yoga exercises and Mantra Meditation
|
Active Comparator: Control I
8 weeks Minimal treatment 16 weeks Multimodal specific treatment Definitions Minimal treatment: drug continuation under medical supervision Multimodal specific treatment: Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR MBLM: 8-week course Meditation Based Lifestyle Modification MBLM-Consolidation: weekly Mantra-Meditation, monthly Life-Ethics |
Drug continuation under medical supervision
Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl.
Yoga, Mantra, MBSR
|
Active Comparator: Control 2
Definitions 24 weeks Multimodal specific treatment Minimal treatment: drug continuation under medical supervision Multimodal specific treatment: Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR MBLM: 8-week course Meditation Based Lifestyle Modification MBLM-Consolidation: weekly Mantra-Meditation, monthly Life-Ethics |
Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl.
Yoga, Mantra, MBSR
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Beck Depression Index BDI-II
Time Frame: Baseline, 4 weeks, 8 weeks. Follow-up 24 weeks
|
Change of depressive Symptoms
|
Baseline, 4 weeks, 8 weeks. Follow-up 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Freiburg Mindfulness Inventory (FMI)
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
The FMI (14 item version; FMI-14) is a widely used instrument that assesses trait mindfulness that has been validated in a number of studies.
This short form of the originally 30-items questionnaire provides robust and psychometrically stable (alpha = .86)
properties.
It is semantically independent from a Buddhist or meditation context (Walach, Buchheld, Buttenmüller, Kleinknecht, & Schmidt, 2006).
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Mindful Attention Awareness Scale (MAAS)
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
The MAAS (K.
W. Brown & Ryan, 2003) is a 15-item scale designed to assess a core characteristic of dispositional mindfulness, namely, open or receptive awareness of and attention to what is taking place in the present.
The scale shows strong psychometric properties and has been validated with college, community, and cancer patient samples.
Correlational, quasi-experimental, and laboratory studies have shown that the MAAS taps a unique quality of consciousness that is related to, and predictive of, a variety of self-regulation and well-being constructs.
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Perceived Stress Scale (PSS-10)
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
The Perceived Stress Scale (Cohen, Kamarck, & Mermelstein, 1983) is the most widely used psychological instrument for measuring the perception of stress.
It is a measure of the degree to which situations in one's life are appraised as stressful.
Items were designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives.
The scale also includes a number of direct queries about current levels of experienced stress.
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Brief Symptom Checklist (BSI-18)
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
The BSI-18 (Franke et al., 2017) contains the three six-item scales somatization, depression, and anxiety as well as the Global Severity Index (GSI), including all 18 items.
The BSI-18 is the latest and shortest of the multidimensional versions of the commonly used Symptom-Checklist 90-R.
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Aachen Self-Efficacy Questionnaire (Aachener Selbstwirksamkeitsfragebogen, [ASF])
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
The ASF assesses generalized self-efficacy as well as specific factors such as achievement, social interaction and body- related self esteem.
Its internal consistency (Chronbach's α) is 0.90 for the general scale, and 0.74-0.84
for its subscales.
The test-retest reliability for the ASF is rtt 0.66 over a period of eight weeks (Flatten, Wälte, & Perlitz, 2008).
|
Baseline, 8 weeks; Follow-up 24 weeks
|
SpREUK-P-SF17
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
This instrument (Bussing, Reiser, Michalsen, & Baumann, 2012) was designed to measure the engagement frequencies of a large spectrum of organized and private religious, spiritual, existential and philosophical practices.
It avoids the intermix of cognitive / emotional attitudes and convictions on the one hand with the engagement in forms of practice (action, behaviour) on the other.
To account for the fact of institutional religiosity declines not only in Europe, and the alternative use of various existing esoteric and religious resources, the instrument differentiates both the frequency of conventional forms of spirituality/religiosity, and also more reflecting or philosophical practice and nature/environment- oriented practices.
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Triguna Scale (TGS)
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
TGS is an instrument to rate a variety of psychosocial traits (e.g.
cognition, motivation, social behavior etc.) according to tri-guna model of Yoga philosophy (M.
Puta, 2016; Maika Puta & Sedlmeier, 2014).
The reliability of the majority of the 27 scales corresponds to reliability values of established personality inventories: Cronbach's α of 24 subscales is above .7.
The internal consistencies of the other three subscales don't meet this standard, but their values are still above .6.
Measures determining the validity of the inventory are very good.
The exploratory factor analysis of the second study shows that all scales consist of three factors, each of which can be related to one of the gunas.
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Transgression-Related Interpersonal Motivations Inventory (TRIM)
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
The TRIM is a self-report instrument that assesses the motivations assumed to underlie forgiving: Avoidance and Revenge.
Responses to 12 statements referring to a transgression recipient's current thoughts and feelings about the transgressor are scored on a 5-point Likert-type scale.
Recently, a six-item subscale to reflect benevolent motivations toward the transgressor has been under development (contact the first author for details).
The TRIM subscales not only correlate with a variety of relationship, offense, and social-cognitive variables, they have also demonstrated strong relationships to a single-item measure of forgiveness.
The inventory takes approximately 5 minutes to complete (McCullough et al., 1998).
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Brief global measure of client satisfaction (ZUF-8)
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
ZUF-8 is a global, one-dimensional patient satisfaction measurement tool.
It is the German-language adaptation of the American CSQ-8 by Attkisson & Zwick (1982).
Over eight items, the general satisfaction with aspects of the clinic or the received treatment is recorded.
ZUF-8 is particularly suitable for economical screening of patient satisfaction (Schmidt, Lamprecht, & Wittmann, 1989).
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Perseverative Thinking Questionnaire (PTQ)
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
The PTQ (Ehring et al., 2011) is a 15-item questionnaire assessing the tendency to engage in repetitive negative thinking independent of a disorder-specific content.
Items are rated on a scale ranging from 0 (never) to 4 (almost always).
The PTQ consists of three subscales: Core features of repetitive negative thinking (sample item: 'The same thoughts keep going through my mind again and again'.),
perceived unproductiveness of repetitive negative thinking (sample item: 'I keep asking myself questions without finding an answer'.), and repetitive negative thinking capturing mental capacity (sample item: 'My thoughts prevent me from focusing on other things'.).
Confirmatory factor analysis provides support for a 3-factor solution.
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Duke University Religion Index (DUREL)
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
The Duke University Religion Index (DUREL) is a five-item measure of religious involvement, and was developed for use in large cross-sectional and longitudinal observational studies.
The instrument assesses the three major dimensions of religiosity that were identified during a consensus meeting sponsored by the National Institute on Aging.
Those three dimensions are organizational religious activity, non-organizational religious activity, and intrinsic religiosity (or subjective religiosity).
The DUREL measures each of these dimensions by a separate "subscale", and correlations with health outcomes should be analyzed by subscale in separate models.
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Aspects of Spirituality (ASP)
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
The ASP questionnaire was developed to measure a wide variety of vital aspects of spirituality beyond conventional conceptual boundaries in secular societies.
Both expert representatives of various spiritual orientations and also atheists were asked which aspects of spirituality are relevant to them (Büssing, 2006).
Identified motifs we condensed to 40 items of the Aspects of Spirituality (ASP 1.0) questionnaire (7 factors; Cronbach ́s alpha = .94)
(Büssing et al., 2007) which differentiates and quantifies cognitive, emotional, intentional and action-oriented matters of theism/belief, (esoteric) transcendence, existentialism, humanism etc.
The reliable and valid instrument is suited to be used in health care research (Büssing et al. 2007).
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Spirituality as a Resource to Rely on in Chronic Illness (SpREUK-15)
Time Frame: Baseline, 8 weeks; Follow-up 24 weeks
|
The SpREUK was developed to investigate whether or not patients with chronic diseases living in secular societies rely on spirituality as a resource to cope with illness.
The SpREUK questionnaire relies on essential motifs found in counseling interviews with chronic disease patients (i.e., having trust/faith; search for a transcendent source to rely on; reflection of life and subsequent change of life and behavior).
The instrument is suited to be used in health care research (A Büssing, Ostermann, & Matthiessen, 2005).
|
Baseline, 8 weeks; Follow-up 24 weeks
|
Assessment of training and exercise hours
Time Frame: Daily for 8 weeks in intervention group
|
Patients receive weekly working sheets to document daily, cumulative duration of practice.
|
Daily for 8 weeks in intervention group
|
Heart Rate Variability
Time Frame: 24h continuous measurement at Baseline, and at 8 weeks
|
Faros eMotion 180 derived 3-lead ECG Heart Rate Variability (RR-Intervals in ms)
|
24h continuous measurement at Baseline, and at 8 weeks
|
Heart Rate
Time Frame: 8 weeks continuously in 1-minute intervals
|
FitBit Charge 2 derived Heart Rate (beats per minute)
|
8 weeks continuously in 1-minute intervals
|
Sleep duration
Time Frame: 8 weeks continuously
|
FitBit Charge 2 derived sleep duration in minutes
|
8 weeks continuously
|
Activity: Steps per day
Time Frame: 8 weeks continuously
|
FitBit Charge 2 derived steps per day
|
8 weeks continuously
|
Qualitative Interview
Time Frame: After 8 or 24 weeks
|
A single qualitative interview with selected patients (around 10 patients in each group) will be held after at least 8 weeks of treatment to assess qualitative data: Interviews will involve the following domains of exploration
Interviews are an optional part of the study in terms of a mixed model approach to receive quantitative and qualitative data as well. Participants willing to be interviewed have to sign an additional consent for the collection and processing of personal interview data. |
After 8 or 24 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MBLM-D
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Disorder
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
Samsung Medical CenterUnknownMajor Depressive Disorder, Anxiety DisorderKorea, Republic of
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Repurposed Therapeutics, Inc.Unknown
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDepressive Disorder, Major Depressive DisorderUnited States
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Gangnam Severance HospitalCompletedMajor Depressive Disorder(MDD)Korea, Republic of
-
University College, LondonCompletedUnipolar Major Depressive DisorderUnited Kingdom
Clinical Trials on Meditation Based Lifestyle Modification
-
Clínica BazterricaWithdrawn
-
Maharishi International UniversityMedical College of WisconsinCompletedCardiovascular Disease | Coronary Heart DiseaseUnited States
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; Geisinger Clinic; Pennsylvania Department of HealthCompleted
-
Maharishi International UniversityMedical College of WisconsinCompletedHigh Blood Pressure
-
Asan Medical CenterNot yet recruitingHypertension | Chronic Disease | Hyperlipidemias | Lifestyle Risk Reduction
-
Clinical Hospital Centre ZagrebCroatian Institute of Public HealthRecruitingObesity | OverweightCroatia
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of OuluOulu University Hospital; Oulu Deaconess Institute Foundation srCompletedObesity | Physical Activity | Weight Loss | Healthy Obesity, MetabolicallyFinland
-
University of PennsylvaniaSt. Luke's-Roosevelt Hospital CenterCompletedObesity | OverweightUnited States
-
Universität Duisburg-EssenCharite University, Berlin, Germany; University of Witten/Herdecke; Kliniken... and other collaboratorsCompletedHypertension | Metabolic SyndromeGermany